H o m e H o m e

m y S t a g e D x m y S t a g e D x

A b o u t A b o u t

N e w s N e w s

C a r e e r s C a r e e r s

Contact
Paramétrage des cookies

These cookies are necessary for the proper functioning of the site. They cannot be deactivated.

These cookies enable us to measure the number of visits, visitors and sources of traffic to our site (content of paths, etc.), and to compile statistics in order to improve its quality, ergonomics and performance.

Marketing cookies are used to track visitors through websites. The aim is to display ads that are relevant and interesting to the individual user and therefore more valuable to third-party publishers and advertisers.

This site uses cookies to improve our services. By clicking on “accept”, you agree to the use of all cookies.
Go back

Spotlight Medical Secures €6.2M in Seed Funding to Enhance Cancer Treatment Strategies with AI-Powered Prognosis Tests

12 Jul 2024
Press release

Spotlight Medical, a pioneering startup developing AI-driven prognosis tests to assist physicians in selecting the most effective treatment for cancer patients, today announced that it has raised €6.2 million in a seed funding round…

Read more

Read more news

27 Jun 2024

Launch of Spotlight Medical, a spin-off from Institut Curie, dedicated to transforming the way we treat cancer

23 Jun 2026

Spotlight Medical Secures IVDR CE Marking for myStage Dx, Its AI-Enabled Prognostic Test for ER+/HER2 – Early Breast Cancer

06 Sep 2025

(French) Cancer du sein : l’IA au service de la désescalade thérapeutique

No results

© Spotlight Medical 2026